HEALTH● LOW2h ago · Oct 19, 2026, 10:56 AM
Lilly to expand Omvoh for pediatric ulcerative colitis after late-stage trial win
Seeking Alpha Tech · global
Lilly plans to expand the use of its drug Omvoh for pediatric ulcerative colitis following a successful late-stage clinical trial. This development could lead to a new treatment option for children with the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoObesity: Saving can become expensive for the statePolitico EuropeHEALTHBREAKING1h agoThird Ebola case in Kenya highlights US failures amid Trump cuts to key servicesGuardian WorldHEALTH1h agoDelhi High Court permits 16-year-old rape survivor to terminate 31-week pregnancyThe HinduHEALTH1h agoTonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Painmanilatimes.net · Philippines